Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies
Clinical trial NCT04349436 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04349436
- Sponsor
- Replimune, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-15
- Primary completion
- 2029-07-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.